About Spectrin-associated autosomal recessive cerebellar ataxia
Spectrin-associated autosomal recessive cerebellar ataxia is a rare disease catalogued by Orphanet (ORPHA:352403). It is associated with the SPTBN2 gene. Search below for active recruiting clinical trials from ClinicalTrials.gov, or visit the Orphanet expert page for specialist centres, natural history studies, and patient registries.
Clinical Trial Eligibility Tips
What to know before applying to Spectrin-associated autosomal recessive cerebellar ataxia trials.
Search ClinicalTrials.gov for "Spectrin-associated autosomal recessive cerebellar ataxia" or filter by Orphanet code ORPHA:352403 to find disease-specific studies.
Ask your specialist to refer you to a Centre of Expertise — Orphanet lists all accredited centres for this condition worldwide.
Natural history studies and patient registries often enrol before drug trials open — contact the Orphanet patient community first.
Patient Resources
Find recruiting Spectrin-associated autosomal recessive cerebellar ataxia trials
Search 500,000+ studies from ClinicalTrials.gov, filtered for Spectrin-associated autosomal recessive cerebellar ataxia. Updated daily.